Stone Disease

The novel pulsed Thulium: YAG (p-Tm: YAG) is a promising laser and has been shown to dust all prevailing human urinary stone compositions.1 However, available in vitro and in vivo studies had not provided efficiency data on its applicability to differing stone composition types. The authors thus sought to investigate the unexplored question of ablation efficiency with the p-Tm: YAG for stone dust from human urinary stones.
Artificial Intelligence (AI) and its capacity to improve lives has become a contentious topic both within and outside of the medical community. One rapidly evolving application of AI is the development of chat software such as Chat GPT, an open AI chatbot designed to generate written answers to questions in a clear and concise manner. The development of Chat GPT and other AI technologies is particularly significant given the increasing popularity and accessibility of the Internet as a primary source of health information in the United States.1
The novel pulsed thulium:yttrium-aluminium-garnet (p-Tm:YAG) laser has only been recently introduced into clinical practice. The authors questioned whether the novel p-Tm:YAG laser is able to dust all known prevailing human urinary stone compositions. Senior urologists would remember the frequency-doubled double-pulse neodymium:YAG (FREDDY) laser which was originally looked at as a potential lithotripsy tool, till it was found ineffective against cystine stones.1,2
The study aims to determine whether the use of a Ureteral Access Sheath (UAS) is a significant predictor of success in Retrograde Intrarenal Surgery (RIRS) for the treatment of renal stones.
The prevalence of stone disease is increasing in our Medicare patient population. Previously identified trends for increasing ureteroscopy and decreasing shockwave lithotripsy continue in this more contemporary series.
Page 1 of 2